Hoffman ALS Clinical Trial Awards Program
Funds early-stage clinical trials for novel or repurposed ALS therapeutics and imaging tracers.
About
The Hoffman ALS Clinical Trial Awards Program sits under The ALS Association and funds early- to mid-stage phase 1 or phase 2a clinical trials for ALS. It supports novel or repurposed therapeutics, either disease-modifying or symptomatic, and imaging tracers, with total awards of up to $1,000,000 over two or three years.
The program is open to academic and industry investigators worldwide. It exp…
BiotechNeurotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.